Topics

Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.

Articles

Stephanie L. Woerner, PhD, director and principal research scientist at the MIT Center for Information Systems Research, discusses the outlook for next year among biopharma firms.

Expert: Digital Transformation is Key Part of Biopharma C-Suite Goals for 2024

A demand-driven methodology for data standardization across multiple streams of acquisition could improve the sharing of real-world data worldwide.

Improved Data Sharing, Collaborative Learning Could Enhance Real-World Data Analysis

New E2E workflow orchestration service is expected to simplify the processes of health systems and retail pharmacies while also reducing the risk of recalled items reaching patients.

TraceLink Introduces Digital Recalls Solution 

Financial commitment further strengthens IntegriChain’s platform as a source for pharma manufacturers' commercialization and market access goals.

Nordic Capital Purchases Majority Share in IntegriChain

Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.

Access Insights 2023: Price Transparency Data in Pharma

Studies with Zenith-CKD showed significant albuminuria reduction.

AstraZeneca Reports Positive Results Phase IIb Chronic Kidney Disease Trial

Boehringer Ingelheim Delivers Promising Results in Phase II Chronic Kidney Disease Trial

There are a slew of specialist and boutique companies set up to provide high quality services and to meet the changing needs of the pharma industry.

Creating Strategic Relationships: The Changing Face of Contract Research Organizations and Sponsor Partnerships

With new tech acquisition, the software company also introduces a new branded AI assistant for mobile devices specifically for the life sciences sector.

Aktana Attains Tact.ai’s Field Engagement and Conversational AI Technology

Exagamglogene autotemcel (exa-cel) has shown the potential to be a landmark therapy in preventing episodes of excruciating pain among patients with sickle cell disease.

Data & Technology